Enterprise Value
174.7M
Cash
277.9M
Avg Qtr Burn
-11.87M
Short % of Float
40.42%
Insider Ownership
7.00%
Institutional Own.
85.97%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|